Forward Science recently announced the official launch of PerioStōm®, an innovative oral wound dressing designed for dental iatrogenic procedures such as scaling and root planing (SRP).
The product has been approved by the US Food and Drug Administration (FDA) and its core ingredient is chitosan microspheres, a biocompatible polymer with antibacterial, anti-inflammatory and anti-biofilm properties.
According to Forward Science, PerioStōm® is designed to effectively protect oral mucosal tissue and accelerate the postoperative repair process by continuously releasing chitosan in the treatment area.
The stainless steel applicator that comes with the product has a diameter similar to that of a traditional dental curette, which can accurately deliver the agent to the bottom of the periodontal pocket for targeted treatment.
“PerioStōm® will bring real changes to the dental industry. I know the word “changing the industry” has been overused, but this time, we really did it.” said Dr. Brian Pikkula, Chief Scientific Officer of Forward Science.
“This is the longest project in our company’s history, and the results are compelling. We are confident that this product can be launched.”
Chitosan, the key ingredient in PerioStōm®, has shown excellent performance in reducing biofilm formation and inhibiting periodontal pathogens such as Porphyromonas gingivalis, making it an ideal adjunct to post-SRP care.
Forward Science points out that the product not only helps relieve patients’ post-operative discomfort, but also improves overall treatment outcomes.
Robert Whitman, CEO of Forward Science, said: “PerioStōm® is the result of our ten years of hard work and represents our team’s unremitting efforts on the road of dental innovation.
We are proud to provide clinicians with a solution that is both high-quality and cost-effective.”
Ellen Myers, Executive Director of Clinical Affairs and Strategic Markets at Forward Science, emphasized: “PerioStōm® is a key breakthrough in periodontal care.
It not only enhances the standard periodontal treatment procedure, but also more precisely responds to a long-standing unmet clinical need to help doctors achieve more stable and better treatment results.”
Related topics:
